Skip to main content
. 2018 May 29;12:174–183. doi: 10.1016/j.omtn.2018.05.004

Figure 1.

Figure 1

Expressions of uc.454 in Clinical Specimens and Lung Cancer Cell Lines

Relative expression of uc.454 was detected in 100 paired clinical specimens (tumor and non-tumor tissues) by real-time qPCR. (A) uc.454 was significantly lower expressed in tumor tissues than in non-tumor tissues. (B) Real-time qPCR experiments showed that expression of uc.454 was significantly higher in normal lung cell line (BEAC-2B and 16HBE) than in LC cell lines (SPC-A-1, NCI-H2170, NCI-H1299, 95-D, NCI-H2170, and SPC-A-1). (C) Expression of uc.454 was significantly lower in bigger tumors. (D) Expression of uc.454 was significantly lower in more advanced tumor stages. All expressions of uc.454 were normalized to GAPDH. The results of real-time qPCR were presented as 2−ΔΔCT change in experimental groups relative to control groups. Error bars represent mean ± SD of triplicate experiments. *p < 0.05; **p < 0.01.